However, this trial studied secondary cardiovascular prevention, i.e
Besides plant-derived phytocannabinoids and endogenous endocannabinoids, synthetic cannabinoids have also been developed and studied
Dosing Inaccuracy : Compounded tirzepatide may not contain the stated amount of active ingredient, leading to underdosing (reduced efficacy) or overdosing (increased adverse effects)
Lower back pain is not listed as a common or characteristic adverse effect in the FDA-approved prescribing information for semaglutide formulations (Ozempic, Wegovy, or Rybelsus)
Semaglutide is currently facing a shortage and limited access, and Tirzepatide might follow suit as it becomes more prevalent
This means a gap of one week between your last Wegovy dose and your first Mounjaro dose is generally well-tolerated